がん細胞は,免疫を回避するために単細胞媒介のT細胞刺激を損なう

Anais Elewaut^1,2, Guillem Estivill^1,2, Felix Bayerl³

¹Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.

Nature

|November 28, 2024

まとめ

炎症性モノサイトは,T細胞に腫瘍抗原を提示する,抗腫瘍免疫の鍵です. ガン細胞のシグナル伝達がこれを阻害し,I型インターフェロンを減らし,プロスタグランジンE2を増加させ,T細胞の反応を阻害する.

科学分野:

免疫学
癌生物学
細胞メカニズム

背景:

腫瘍の微小環境 (TME) は,抗腫瘍免疫反応に大きな影響を及ぼします.
CD8+T細胞は,TMEの特殊なニッチ内でエフェクタ機能を発達させる.
従来の dendritic 細胞は T 細胞と相互作用することが知られているが,他の細胞プレーヤーとメカニズムは不明である.

研究の目的:

腫瘍内T細胞刺激における炎症性単細胞の役割を調査する.
TME内のT細胞反応に影響を与える分子メカニズムを解明する.
抗腫瘍免疫を強化するための戦略を特定する.

主な方法:

抗原表現における炎症単細胞機能の分析
単細胞による抗原獲得のための"クロスドレッシング"メカニズムの調査.
MAPKシグナル伝達,タイプIインターフェロン (IFN-I),およびプロスタグランジンE2 (PGE2) のT細胞刺激への影響の評価

主要な成果:

炎症性モノサイトは"クロスドレッシング"を通じてT細胞に腫瘍抗原を伝達する.
癌細胞におけるMAPKシグナル伝達が過度に活発化すると,IFN- Iの産生が抑制され,PGE2の分泌が増加する.
この抑制は単細胞機能と腫瘍内T細胞刺激を損なう.

結論:

炎症性単細胞は腫瘍内T細胞を刺激する上で重要な役割を果たします.
PGE2とIFN- Iを調節することでT細胞免疫を阻害する.
PGE2を標的とし,IFN- Iを強化すると,T細胞媒介免疫が回復し,免疫療法の結果が改善されます.

さらに関連する動画

09:57

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

22.4K

10:59

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment

Published on: November 23, 2017

12.3K

関連する概念動画

02:17

The Tumor Microenvironment

6.5K

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

6.5K

02:53

Adaptive Mechanisms in Cancer Cells

5.7K

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

5.7K

02:40

Cancer Stem Cells and Tumor Maintenance

4.9K

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

4.9K

01:27

Cytotoxic T Cells-mediated Immune Response

849

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

849

01:27

Tumor Immunotherapy

480

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

480

02:30

Metastasis

5.5K

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...